• Dr. Paul J. Chai Named New Chief of Cardiothoracic Surgery

    August 01, 2019

    ATLANTA (May 22, 2019) –Children’s Healthcare of Atlanta has named Paul J. Chai, MD, as Chief of Cardiothoracic Surgery. In his new role, effective May 13, 2019, Dr. Chai leads the Children’s Cardiothoracic Surgery Program and joins current Chief of the Children’s Cardiac Services, William Mahle, MD, as Co-Chief of the Children’s Heart Center. To read more, click here.

  • Dr. Xu Receives Emory I3 Venture Award

    May 30, 2019

    Emory's Venture Research Awards identify promising early-stage concepts with commercial potential that do not yet qualify for funding from external sources. Twelve proposals from 11 departments were submitted and more than 15 faculty, staff and partners with specialized expertise in innovation and entrepreneurship participated in the review process.  Congratulations to Dr. Xu on being one of five recipients!  !  To read more, click here.

  • Dr. Cho Published in Nature Scientific Reports

    May 28, 2019

    "A rat model of complete atrioventricular block recapitulates clinical indices of bradycardia and provides a platform to test disease-modifying therapies" Complete atrioventricular block (CAVB) is a life-threatening arrhythmia. A small animal model of chronic CAVB that properly reflects clinical indices…

  • Dr. Davis Promoted to Full Professor

    May 28, 2019

    Michael E. Davis has been promoted to full professor with tenure effective September 1, 2019, by the Board of Trustees at Emory University. Davis is an associate professor in both cardiology and biomedical engineering (BME) in the Wallace H. Coulter Department…

  • Dr. Davis Honored at 2019 Educator Appreciation Day

    May 21, 2019

    In recognition of Educator's Day, the Emory School of Medicine Recognitions Committee sent out a call for nominations for educators across the School of Medicine who go above and beyond the call of duty as teachers and mentors. …

  • Enduring Hearts and HeRO Featured on CBS46

    May 10, 2019

    (CBS46) -- For heart transplant recipients, receiving the organ is just the beginning. What follows is a lifetime of drugs, doctor visits, and the ongoing possibility of another transplant.   Click here to view the interview. …

  • Davis Lab Pub:  Electrospun Nanofiber-Based Patches for the Delivery of Cardiac Progenitor Cells

    May 07, 2019

    Congenital heart disease (CHD) is the number one cause of birth defect-related death because it often leads to right ventricular heart failure (RVHF). One promising avenue to combat this RVHF is the use of cardiac patches comprised of stem cells…

  • Dr. Cho Awarded RO1 Patterning Myocardial Specification of Human Pluripotent Stem Cells

    April 05, 2019

     Human pluripotent stem cells (hPSCs) originate from either embryonic or transcription factor-induced origins. Under controlled conditions, they recapitulate cardiac development in vitro and give rise to cardiac myocytes of all subtypes. The de novo cardiac myocytes are the best…